Improving Therapeutic Learning in Depression: Proof of Concept

改善抑郁症的治疗学习:概念证明

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Despite advances in both pharmacotherapy and psychotherapy for major depression, non-response and partial-response remain relatively common outcomes, motivating the search for new treatments. This application is concerned with the development of one such novel treatment, based on one of the particular successes of translational research: the augmentation of exposure-based cognitive-behavior therapy (CBT) with d-cycloserine (DCS). In this application, we propose a study of the efficacy of DCS for augmenting therapeutic learning relevant for the treatment of depression (i.e., outside the extinction learning where DCS has been shown to have success). Specifically, appropriate to an R-21 mechanism (PA-11-261), we investigate the role of DCS in enhancing declarative memory in depressed individuals, as evaluated by standardized tests and the retention of cognitive therapy session material. In seeking to extend the therapeutic targets for DCS augmentation, we are also proposing to study an active comparison agent. This agent, modafinil, appears to offer cognitive enhancing effects among both sleep deprived and non-sleep deprived individuals, but also appears to have drug-state (e.g., mood and side) effects that are not characteristic of DCS augmentation. For this reason, drug-context effects may affect memory retention over time. Hence, we will evaluate memory enhancement effects both during the period of drug action as well as one week later when no drug is taken. Overall, we propose to examine cognitive function and memory performance over 4 study sessions in 96 men and women with major depression, who, in a double-blind fashion, will be randomly assigned to either: (1) 50mg DCS, (2) 250mg DCS, (3) 100mg modafinil, or (4) placebo administered on Study Weeks 2 and 3. The memory tests include both items unique to a given study week (i.e., item categorization, the HVLT, and digits backward), and memory tasks that are repeated over time (logical memory tasks and the cognitive therapy content), that allow assessment of memory and retention effects across one-week periods (i.e., from Week 2 to Week 3 and from Week 3 to Week 4). We believe this study is the next logical step toward the goal of extending CBT augmentation effects for depression. If study aims are achieved in this R21 study, we will proceed with a R01 application at the conclusion of the funding period, working to show whether augmentation of therapeutic learning leads to an earlier and/or more robust treatment response for depressed patients undergoing CBT.
项目摘要/摘要 尽管药物治疗和心理治疗在治疗重度抑郁症方面都取得了进展,但无反应和 部分应答仍然是相对常见的结果,促使人们寻找新的治疗方法。这 应用涉及一种这样的新疗法的开发,基于一种特殊的 翻译研究的成功:基于暴露的认知行为疗法(CBT)的加强 D-环丝氨酸(Dcs)。在这一应用中,我们提出了一项关于分布式控制系统对于增强 与抑郁症的治疗相关的治疗性学习(即,在消退学习之外,在哪里 已经被证明是成功的)。具体地说,对于R-21机制(PA-11-261),我们 研究DCs在增强抑郁个体的陈述性记忆中的作用,通过以下评估 标准化测试和认知治疗课程材料的保留。在寻求延长治疗性治疗 为了增强DC的靶点,我们还建议研究一种活性比较剂。这位特工, 莫达非尼似乎在睡眠剥夺和非睡眠剥夺中都提供了认知增强效果 个体,但似乎也有药物状态(例如,情绪和副作用)的影响,这不是DCS的特征 增强功能。出于这个原因,药物背景效应可能会随着时间的推移影响记忆保持。因此,我们将 评估药物作用期间和一周后的记忆增强效果 有人吸毒了。总体而言,我们建议通过4项研究来检查认知功能和记忆表现 对96名患有严重抑郁症的男性和女性进行治疗,他们将以双盲方式随机 分配给:(1)50毫克DCS50毫克,(2)250毫克DCS250毫克,(3)莫达非尼100毫克,或(4)研究中使用的安慰剂 记忆测试包括给定研究周所特有的两个项目(即,项目分类, HVLT和数字倒退),以及随时间重复的内存任务(逻辑内存任务 认知疗法内容),允许在一周内评估记忆和保持效果 (即从第2周到第3周和从第3周到第4周)。我们相信这项研究是合乎逻辑的下一步 朝着扩大CBT对抑郁症的增强效应的目标前进。如果在R21中实现了研究目标 研究,我们将在资助期结束时继续R01申请,努力表明 治疗学习的增强导致抑郁症的更早和/或更有力的治疗反应 接受CBT的患者。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael W. Otto其他文献

Constructing a model of change: Clinical commentary on a complex case
  • DOI:
    10.1016/s1077-7229(00)80013-9
  • 发表时间:
    2000-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael W. Otto
  • 通讯作者:
    Michael W. Otto
The effects of physical activity on sleep: a meta-analytic review
  • DOI:
    10.1007/s10865-015-9617-6
  • 发表时间:
    2015-01-18
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    M. Alexandra Kredlow;Michelle C. Capozzoli;Bridget A. Hearon;Amanda W. Calkins;Michael W. Otto
  • 通讯作者:
    Michael W. Otto
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
使用阿普唑仑或氯硝西泮急性治疗惊恐障碍后的长期结果。
  • DOI:
    10.1097/00004714-199308000-00005
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    M. Pollack;Michael W. Otto;G. Tesar;Lee S. Cohen;Samantha Meltzer;Jerrold F. Rosenbaum
  • 通讯作者:
    Jerrold F. Rosenbaum
Cognitive-behavioral therapy for social anxiety disorder: model, methods, and outcome.
社交焦虑症的认知行为治疗:模型、方法和结果。
Quick start file for the panel "Labour market and social security" (PASS): analysing the PASS data using SPSS/PASW
“劳动力市场和社会保障”(PASS) 小组的快速启动文件:使用 SPSS/PASW 分析 PASS 数据
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Benjamin Fuchs;S. Lödel;Michael W. Otto
  • 通讯作者:
    Michael W. Otto

Michael W. Otto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael W. Otto', 18)}}的其他基金

2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
2/2-CO2 反应性作为暴露治疗无反应的生物标志物
  • 批准号:
    10614510
  • 财政年份:
    2022
  • 资助金额:
    $ 24.66万
  • 项目类别:
2/2-CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
2/2-CO2 反应性作为暴露治疗无反应的生物标志物
  • 批准号:
    10363061
  • 财政年份:
    2022
  • 资助金额:
    $ 24.66万
  • 项目类别:
Engaging Working Memory and Distress Tolerance to Aid Smoking Cessation
调动工作记忆和抗压能力来帮助戒烟
  • 批准号:
    9928212
  • 财政年份:
    2018
  • 资助金额:
    $ 24.66万
  • 项目类别:
Engaging Working Memory and Distress Tolerance to Aid Smoking Cessation
调动工作记忆和抗压能力来帮助戒烟
  • 批准号:
    9767106
  • 财政年份:
    2018
  • 资助金额:
    $ 24.66万
  • 项目类别:
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine
使用 D-环丝氨酸增强恐慌和减少吸烟治疗
  • 批准号:
    8731846
  • 财政年份:
    2013
  • 资助金额:
    $ 24.66万
  • 项目类别:
Enhancing Panic and Smoking Reduction Treatment with D-Cycloserine
使用 D-环丝氨酸增强恐慌和减少吸烟治疗
  • 批准号:
    8790514
  • 财政年份:
    2013
  • 资助金额:
    $ 24.66万
  • 项目类别:
1/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic Disorder
恐慌症中的 1/3 暴露 D-环丝氨酸增强剂和遗传调节剂
  • 批准号:
    7795774
  • 财政年份:
    2008
  • 资助金额:
    $ 24.66万
  • 项目类别:
Excellence In Training: The Center for Anxiety and Related Disorders at BU
卓越培训:波士顿大学焦虑及相关疾病中心
  • 批准号:
    7558423
  • 财政年份:
    2008
  • 资助金额:
    $ 24.66万
  • 项目类别:
Excellence In Training: The Center for Anxiety and Related Disorders at BU
卓越培训:波士顿大学焦虑及相关疾病中心
  • 批准号:
    8268550
  • 财政年份:
    2008
  • 资助金额:
    $ 24.66万
  • 项目类别:
Excellence In Training: The Center for Anxiety and Related Disorders at BU
卓越培训:波士顿大学焦虑及相关疾病中心
  • 批准号:
    7693703
  • 财政年份:
    2008
  • 资助金额:
    $ 24.66万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 24.66万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了